Yury Verlinsky
Pioneering scientist in the field of reproductive genetics
Yury Verlinsky was a pioneering scientist in the field of reproductive genetics. He is best known for his work in developing and advancing preimplantation genetic diagnosis (PGD), a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy.
Early Life and Education[edit | edit source]
Yury Verlinsky was born in Soviet Belarus. He pursued his higher education in genetics and embryology, which laid the foundation for his future contributions to reproductive medicine.
Career[edit | edit source]
Verlinsky's career was marked by significant advancements in the field of reproductive genetics. He founded the Reproductive Genetics Institute in Chicago, where he and his team developed techniques for PGD. This method allows for the detection of genetic abnormalities in embryos, enabling the selection of healthy embryos for implantation.
Preimplantation Genetic Diagnosis[edit | edit source]
Preimplantation genetic diagnosis (PGD) is a procedure used to screen embryos for specific genetic conditions before they are implanted in the uterus. This technique is particularly useful for couples at risk of passing on genetic disorders. Verlinsky's work in this area has helped countless families avoid the transmission of serious genetic diseases.
Contributions to Medicine[edit | edit source]
Verlinsky's contributions to medicine extend beyond PGD. He was involved in research related to stem cells and genetic counseling. His work has had a lasting impact on the field of reproductive genetics and has paved the way for further advancements in genetic screening and therapy.
Legacy[edit | edit source]
Yury Verlinsky's pioneering work in reproductive genetics has left a significant legacy. His development of PGD has provided a valuable tool for preventing genetic diseases and has improved the success rates of IVF treatments. His contributions continue to influence the field of reproductive medicine and genetics.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
